Oscar Health

Oscar Health, Inc. operates as a health insurance company which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Oscar Health reports robust growth and profitability outlook for 2023

Oscar Health's 2022 performance showcased strong growth in membership, improved financial ratios, and a focus on efficiency and profitability in the insurance business.
The company's strengths lie in exceeding targets for capital, stable premiums, and leveraging investment income for competitive advantage.
Challenges include financial transparency and managing risk pool dynamics, while opportunities exist in market expansion, PBM contract benefits, and margin expansion strategies.
Overall, Oscar Health's strategic focus on growth, efficiency, and profitability positions it well for future success in the insurance market.

Oscar Health achieves Q1 profitability, focuses on tech innovation

Oscar Health's Q1 2023 earnings call highlighted strong financial performance, operational efficiency, and a strategic focus on profitability priorities.
While facing challenges such as reshaping strategies and market-specific dynamics, the company is well-positioned to leverage opportunities for growth and innovation.
With a mission-driven approach, a growing member base, and a commitment to enhancing technology, Oscar Health aims to sustain profitability and market competitiveness.

Oscar Health reports strong Q2 earnings, eyes growth opportunities

Oscar Health's Q2 performance reflects positive trends in profitability, membership growth, and strategic planning for future expansion.
While facing challenges in pricing strategies and achieving profitability targets, the company is well-positioned to capitalize on growth opportunities.
With a focus on innovation, customer satisfaction, and market expansion, Oscar Health aims to strengthen its competitive position in the healthcare industry.

Oscar Health excels in Q3, eyes profitability in 2024

Oscar Health's Q3 2023 earnings call highlighted strong performance metrics, a focus on profitability in 2024, and strategic initiatives to drive growth and enhance member satisfaction. While facing challenges in narrowing EBITDA losses, the company remains optimistic about its trajectory and expressed confidence in its strategic direction and employee dedication.

Oscar Health achieves insurance profitability, eyes growth amid market changes

Oscar Health's Q4 2023 Earnings Call highlighted achievements in insurance company profitability and significant improvements in total company adjusted EBITDA.
The company is well-positioned for profitability in 2024, focusing on serving over 1.3 million members with new products and technology enhancements.
Challenges include navigating potential market dynamics changes due to ACA subsidy adjustments, but Oscar Health is proactively addressing these concerns.

Oscar Health posts record revenue and profitability, eyes market expansion

Oscar Health delivered robust Q1 results, showcasing strong revenue growth, improved profitability, and strategic market expansion initiatives.
Despite facing challenges in achieving total company adjusted EBITDA profitability, the company's financial stability and growth prospects remain promising.
With a focus on operational efficiency and long-term strategic vision, Oscar Health is well-positioned to capitalize on market opportunities and drive sustained growth.

Oscar Health reports strong Q2 results, eyes growth through technology

Oscar Health's Q2 2024 earnings call showcased robust financial performance, driven by revenue growth and improved EBITDA. The company's membership expansion and strategic focus on technology-driven engagement are key strengths. Challenges include policy uncertainties and meeting raised guidance, while opportunities exist in market resonance and technological advancements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Harvard Business School classmates Josh Kushner, Mario Schlosser, and Kevin Nazemi decide to start a company to demystify health insurance.

Oscar, named after Kushner's great grandfather, raises $51.5 million through Series A, AA, and AAA funding from Gary Vaynerchuk, Dave Gilboa, Khosla Ventures, Lerer Ventures, General Catalyst Thrive Capital, Founders Fund, Kal Vepuri, BoxGroup and more, with a pre-money valuation of $70 million.

Series A4 funding drops a nice $30 million from investors into Oscar's wallet, bumping its valuation to $310 million.

Oscar secures $80 million in Series A5 funding, mostly from Formation 8. Pre-money valuation reaches $500 million.

Nearly 150,000 members call themselves Oscar-insured across four states alone (NY, NJ, CA, & TX).

Oscar's member services team sets up camp in Tempe, Ariz.

Mount Sinai Health System partners to open the Oscar Center, offering primary care, mental health, and wellness services to members—sort of like a fancy urgent care. 😎

Oscar offers coverage to New York small businesses for their employees. 

The Cleveland Clinic collab drops in the Midwest market to cover individuals across northeastern Ohio. 

Oscar expands to new regions, including Tennessee, Ohio, Texas, New Jersey, and California.

Hey, y’all: A partnership with Humana helps Oscar cover small businesses up to 50 employees in Nashville, Tenn.

Series G round nets Oscar $165 million in funding, zooming the estimated value to a whopping $3.2 billion.

Alphabet (parent company to Google) decides to invest, cutting Oscar a check for $375 million.

The "Cigna + Oscar" collab brings together Cigna's vast network to Oscar's member-focused experience for small businesses. 

Gary Vaynerchuk and Khosla Ventures go for round 2, but this time, a sweet $225 million with the help of Builders VC.

Tiger Global Management invests $140 million in Oscar, as the company's member count exceeds 400,000.

Oscar begins trading on the New York Stock Exchange under the ticker $OSCR.

NEW YORK--(BUSINESS WIRE)--Health tech company Oscar Health, Inc. (NYSE: OSCR) today announced its financial results for the second quarter ended June 30, 2023. “Our strong second quarter results demonstrate that our pricing discipline, renewed operational focus, and solid execution are driving meaningful impact across our business,” said Mark Bertolini, CEO of Oscar. “Based on strong year-to-date performance, we now expect to be towards the low-end of our MLR guidance and high-end of our full.

Oscar Health Announces Strong Financial Results for Second Quarter 2023

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, will release its second quarter 2023 financial results after market close on Tuesday, August 8, 2023. Management will review these results in a conference call beginning at 5:00 PM (ET). The call-in number and webcast link are as follows: Live Call: (877) 400-4403 Conference ID: 6577079 Webcast Link The call will be archived and available on Oscar's.

Oscar Health, Inc. 2023 Second Quarter Conference Call

Even with a (most likely temporary) halt in two important markets, Florida and California producing a small retreat in membership growth, Oscar Health is still making considerable progress. It had its first AEBITDA profitable quarter, and although it will still produce losses for the year, its cash burn will decline, and profitability is in sight next year. Even after having quadrupled in just under 6 months, the shares are still dirt cheap if that progress continues according to plan.

Oscar Health Shares Quadrupled, But They Are Still Cheap

Oscar Health has been growing exceptionally quickly, continuing to grow revenues at over 50% y/y even though it is now generating more than $1B in quarterly revenue. It also put a new CEO in place last quarter, a longtime executive at Aetna who also did a stint at Bridgewater (hedge fund). The firm's most recent quarter saw positive adjusted profitability for the first time as well as ongoing progress towards positive GAAP profits.

Oscar Health: High Growth And Improving Profitability Make It A Buy

Oscar Health offers health plans to individuals and groups and has Medicare Advantage plans. Institutional buyers help drive the stock's shares higher.

Why Shares of Oscar Health Soared This Week

Oscar Health, Inc. (NYSE:OSCR ) Q1 2023 Earnings Call May 9, 2023 5:00 PM ET Company Participants Cornelia Miller - Vice President, Corporate Development and Investor Relations Mark T. Bertolini - Chief Executive Officer Sid Sankaran - Interim Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Joshua Raskin - Nephron Michael Ha - Morgan Stanley Nathan Rich - Goldman Sachs Operator Good afternoon.

Oscar Health, Inc. (OSCR) Q1 2023 Earnings Call Transcript

NEW YORK--(BUSINESS WIRE)--Health tech company Oscar Health, Inc. (NYSE: OSCR) today announced its financial results for the first quarter ended March 31, 2023. "I believe that Oscar has the power to transform the healthcare system, and I am excited to lead the company through this next phase of its evolution," said Mark Bertolini, CEO of Oscar. "First quarter results demonstrate solid fundamentals across the business and that we're executing well against our plan. As we focus on the opportunit.

Oscar Health Announces Results for First Quarter 2023 With Meaningful YoY Improvements Across all KPIs

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced that Chief Executive Officer, Mark Bertolini, and Chief Financial Officer, Sid Sankaran, will present at the BofA Securities 2023 Health Care Conference on Wednesday, May 10, 2023 at 3:00 PM PT (6:00 PM ET) in Las Vegas, NV. All interested parties are invited to listen to a webcast of the presentation by visiting www.ir.hioscar.com a.

Oscar Health, Inc. Announces Participation in BofA Securities 2023 Health Care Conference

SAN FRANCISCO & NEW YORK--(BUSINESS WIRE)--Today, Ciox Health®, a Datavant company, and Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built around a full stack technology platform, announced that they have renewed and expanded their digital services agreement. Under the expanded agreement, Oscar will have access to the Datavant Switchboard via Ciox to securely request, retrieve, and digitally deliver clinical data.

Oscar Health Renews and Expands Relationship with Digital Solutions Platform Provider Ciox Health

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, will release its first quarter 2023 financial results after market close on Tuesday, May 9, 2023. Management will review these results in a conference call beginning at 5:00 PM (ET).

Oscar Health, Inc. 2023 First Quarter Conference Call

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today released its inaugural Environmental, Social, and Governance (ESG) Report for 2022. The report outlines the strategies and initiatives that Oscar has developed, and continues to iterate, to help build a more sustainable and equitable future within its organization and communities.

Oscar Health, Inc. Releases 2022 Environmental, Social, and Governance (ESG) Report

Oscar Health, Inc. (OSCR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Oscar Health, Inc. (OSCR) Stock Jumps 56.3%: Will It Continue to Soar?

Oscar Health (NYSE: OSCR ) stock is heading higher on Tuesday after the healthcare company announced Mark Bertolini as its new CEO. That news has holders of OSCR stock excited today as Bertolini is a veteran in the healthcare field.

Why Is Oscar Health (OSCR) Stock Up 82% Today?

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built around a full-stack technology platform, today announced the appointment of Mark Bertolini to the role of Chief Executive Officer, effective April 3, 2023. Co-Founder Mario Schlosser, will transition to President of Technology, reporting to Mark.

Oscar Health Announces Appointment of Healthcare Veteran Mark Bertolini to CEO; Co-Founder and CEO Mario Schlosser Transitions to President of Technology

Former Aetna Inc. chief executive Mark Bertolini will take over as the CEO of Oscar Health Inc. OSCR, +6.85% , the Wall Street Journal reported Tuesday. Bertolini will take over from co-founder Mario Schlosser, who will stay on with the health insurer in the new role of president of technology.

Oscar Health nabs former Aetna CEO Mark Bertolini for its top post

Oscar Health, Inc. looks almost absurdly undervalued at a market cap of ~$620m. The company has >$3bn cash and is forecasting revenues of >$6bn in FY23 and losses of

Oscar Health: So Many Issues, But Hard To Ignore The Upside Potential

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced that Dr. Sean Martin, MD has been appointed to serve as the company's new Chief Medical Officer, effective immediately. Dr.

Oscar Health, Inc. Appoints Dr. Sean Martin, MD as New Chief Medical Officer

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced that it has renewed its Pharmacy Benefit Manager agreement with CVS Caremark to provide Oscar members with continued access to CVS Caremark's pharmacy network. The agreement between the two organizations is expected to substantially lower costs for Oscar over the course of the contract period, beginning in 2023.

Oscar Health Announces Renewed Agreement With Pharmacy Benefit Manager CVS Caremark

Encouraging 2023 guidance and a pair of analyst price target lifts pushed the shares higher.

Why Oscar Health Stock Was Flying High This Week

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), the first health insurance company built on a full stack technology platform, today announced Co-Founder & CEO, Mario Schlosser, and CFO, Sid Sankaran, will present at the Cowen 43rd Annual Health Care Conference on Monday, March 6, 2023. Oscar is expected to present at approximately 10:30 AM ET through a virtual webcast.

Oscar Health, Inc. to Present at the Cowen 43rd Annual Health Care Conference

Shares of the tech-enabled health insurance company have already doubled this year.

Is Oscar Health a Good Stock to Buy Right Now?

Investors liked the health insurer's latest quarterly update.

Why Oscar Health Stock Is Skyrocketing Today

Oscar Health, Inc. (NYSE:OSCR ) Q4 2022 Earnings Conference Call February 9, 2023 5:00 PM ET Company Participants Cornelia Miller – Vice President of Corporate Development and Investor Relations Mario Schlosser – Co-Founder and Chief Executive Officer Sid Sankaran – Chief Financial Officer Conference Call Participants Michael Ha – Morgan Stanley Jonathan Yong – Credit Suisse Gary Taylor – Cowen Kevin Fischbeck – Bank of America Josh Raskin – Nephron Research Nathan Rich – Goldman Sachs Stephen Baxter – Wells Fargo Operator Good afternoon. My name is Regina and I will be your conference operator today.

Oscar Health, Inc. (OSCR) Q4 2022 Earnings Call Transcript

The digital healthcare arena continues transforming healthcare delivery while broadening access for patients. This, as health technology company and insurance platform Oscar Health told investors on Thursday's (Feb. 9) fourth quarter 2022 earnings call that its membership numbers for the year rose to a record total of 1,151,483.

Oscar Health Nearly Doubled Its Member Base in 2022

Oscar Health, Inc. (OSCR) delivered earnings and revenue surprises of -3.96% and 10.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

News for Oscar Health Stock (OSCR)